MADISON, Wis.—-BioForward, the member-driven organization that represents the state’s biotechnology industry, today announced the 2010 executive committee members of its board of directors.
Go here to read the rest:
BioForward, the State Biotechnology Association Announces 2010 Executive Committee (Business Wire via Yahoo! Finance)
Shares of BioMarin Pharmaceutical Inc. fell Monday after a Brean Murray analyst downgraded the stock citing its value and a lack of detail on the biotechnology company’s midstage drug programs.
Continued here:
BioMarin shares fall, Brean analyst downgrades (AP via Yahoo! Finance)
WASHINGTON, Feb 8 (Reuters) – U.S. drug reviewers questioned effectiveness data from Cell Therapeutics Inc for an experimental lymphoma drug and said the medicine carried substantial side effects, according to documents released on Monday. The Seattle-based biotechnology company is seeking approval to sell pixantrone under the brand name Pixuvri for treating non-Hodgkin’s lymphoma that has …
Here is the original:
(AFX UK Focus) 2010-02-08 14:35 UPDATE 1-US FDA staff questions Cell Therapeutics drug data (Interactive Investor)
Giving the USDA verdict on Food 2030, Jennifer Wilson said the UK is seeking global leadership on food security and has delivered bold statements on contentious issues like product labelling and agricultural biotechnology.
Read the original here:
USDA says Food 2030 vision is short on detail (Food Production Daily)
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Read more from the original source:
3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience (News-Medical-Net)
APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.
Read more here:
Press Release (PharmiWeb)
Northwest Biotherapeutics, Inc., a development stage biotechnology company focused on personalized cancer vaccines to enhance immune system responses to tumors, has retained Market Media Connect as their communications agency of record. Led from its Los Angeles headquarters, Market Media Connect will support Northwest’s communication objectives as the company moves into the next phase of its …
Read more from the original source:
Market Media Connect retained as Northwest Biotherapeutics’ communications agency of record (News-Medical-Net)
Northwest Biotherapeutics, Inc. , a development stage biotechnology company focused on personalized cancer vaccines to enhance immune system responses to tumors, has retained Market Media Connect as their communications agency of record
Read the original post:
Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Record (PR Newswire via Yahoo! Finance)
The first class I observed was a Biotechnology lab….
Excerpt from:
Science Leadership Academy, Philadelphia PA
It represents the amalgamated efforts of the best of the best in robotic engineering, dimensional science, and biotechnology;…
Original post:
Section 8, part 6
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.